S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|J&J, Bayer Aim to Expand Xarelto's Uses (2014/8/29)|
|Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG|
|Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer|
|EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union|
|Two-Year Results From Phase 3 VIVID-DME Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision|
|Regeneron Announces Submission of Application for EYLEA® (aflibercept) Injection in Japan for Macular Edema Following Branch Retinal Vein Occlusion|
|Compugen shares rise on news of positive cancer collaboration with Bayer|
|Merck Announces Second-Quarter 2014 Financial Results|
|UPDATE: Deal lifts Roche; Draghi boosts banks: Europe's stock moves|
|Roche climbs on deal, banks higher: Europe movers|
Click above to view more mutual fund data and stats for bayry - Bayer AG ADR.